Search | OpenScholar

Search results

751 results found

Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy. American journal of human genetics, 104(6), 1210–1222.

Publication: Journal Article

“Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy. American Journal of Human Genetics, 104(6), 1210–1222.”. 2019. American Journal of Human Genetics.

Medical Management and Prevention of Motor Complications in Parkinson's Disease. Neurotherapeutics 2020;17:1339-1365.

Publication: Journal Article

Aradi, SD, and RA Hauser. 2020. “Medical Management and Prevention of Motor Complications in Parkinson’s Disease. Neurotherapeutics 2020;17:1339-1365.”. Neurotherapeutics.

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study. Parkinsonism Relat Disord 2020;80:127-132.

Publication: Journal Article

Mills, KA, RB Schneider, M Saint-Hilaire, GW Ross, RA Hauser, AE Lang, MJ Halverson, et al. 2020. “Cognitive Impairment in Parkinson’s Disease: Associations Between Subjective and Objective Cognitive Decline in a Large Longitudinal Study. Parkinsonism Relat Disord 2020;80:127-132.”. Parkinsonism Relat Disord.

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Front Neurol. 2020;11:576117.

Publication: Journal Article

Hauser, RA, and . 2020. “Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Front Neurol. 2020;11:576117.”. Front Neurol.

On demand therapy for Parkinson's disease patients: Opportunities and choices. Postgrad Med. 2021 Sep;133(7):721-727. doi: 10.1080/00325481.2021.1936087.

Publication: Journal Article

Hauser, RA, PA LeWitt, and CL Comella. 2021. “On Demand Therapy for Parkinson’s Disease Patients: Opportunities and Choices. Postgrad Med. 2021 Sep;133(7):721-727. Doi: 10.1080/00325481.2021.1936087.”. Postgrad Med.

A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson's Disease. Sensors (Basel). 2021 Aug 12;21(16):5437. doi: 10.3390/s21165437. PMID: 34450879.

Publication: Journal Article

Rupprechter, S, G Morinan, Y Peng, T Foltynie, K Sibley, RS Weil, LA Leyland, et al. 2021. “A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson’s Disease. Sensors (Basel). 2021 Aug 12;21(16):5437. Doi: 10.3390/S21165437. PMID: 34450879.”. Sensors (Basel).

Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. J Parkinsons Dis. 2021;11(4):1663-1675. doi: 10.3233/JPD-212672. PMID: 34486986

Publication: Journal Article

Hauser, RA, N Hattori, H Fernandez, SH Isaacson, H Mochizuki, O Rascol, F Stocchi, et al. 2021. “Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, As Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. J Parkinsons Dis. 2021;11(4):1663-1675. Doi: 10.3233/JPD-212672. PMID: 34486986”. J Parkinsons Dis.

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions. 5:100115. doi: 10.1016/j.prdoa.2021.100115. eCollection 2021. PMID: 34888518.

Publication: Journal Article

Lew, MF, RA Hauser, SH Isaacson, D Truong, AT Patel, A Brashear, W Ondo, et al. 2021. “AbobotulinumtoxinA Provides Flexibility for the Treatment of Cervical Dystonia With 500 U/1 mL and 500 U/2 mL Dilutions. 5:100115. Doi: 10.1016/J.prdoa.2021.100115. ECollection 2021. PMID: 34888518.”. Clin Park Relat Disord.

Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review. Mov Disord Clin Pract 2020;7:250-266.

Publication: Journal Article

Wallace, DM, WK Wohlgemuth, LM Trotti, AW Amara, IA Malaty, SA Factor, S Nallu, L Wittine, RA Hauser, and DM Wall. 2020. “Practical Evaluation and Management of Insomnia in Parkinson’s Disease: A Review. Mov Disord Clin Pract 2020;7:250-266.”. Mov Disord Clin Pract.

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease. BMC Neurol 2016:16:90.

Publication: Journal Article

Hauser, RA, J Slawek, Paolo Barone, Elisabeth Dohin, E Surmann, M Asgharnejad, and L Bauer. 2016. “Evaluation of Rotigotine Transdermal Patch for the Treatment of Apathy and Motor Symptoms in Parkinson’s Disease. BMC Neurol 2016:16:90.”. BMC Neurol.